SHIRLEY PATTERSON: Open Payments
NPI 1801408729 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 41 payments from 16 companies in 2025. Trend: 2023 $422 · 2024 $902 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $254 |
| AstraZeneca Pharmaceuticals LP | 6 | $190 |
| Viatris Specialty LLC | 3 | $85 |
| Amgen Inc. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| ABBVIE INC. | 1 | $33 |
| United Therapeutics Corporation | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Baxter Healthcare | 1 | $26 |
| Insmed, Inc. | 1 | $20 |
Products named: NUCALA, TEZSPIRE, YUPELRI, TRELEGY ELLIPTA, DUPIXENT, TEFLARO, Tyvaso, XOLAIR.
Industry payments across IN — which companies pay providers there.
